EVFM (OTC)
EVOFEM BIOSCIENCE INC
$0.008100
+0.000300 (+3.85%)
Prev close: $0.007800
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Saundra L. Pelletier
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.01M
- Employees
- 37
- P/E (TTM)
- —
- P/B (TTM)
- -0.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-0.03 | $0.00 | +0.0000 | +0.00% |
|
Dec 2023 (Q4)
|
$-0.44 | $-0.62 | +0.1822 | +29.28% |
|
Sep 2023 (Q3)
|
$0.10 | $-0.06 | +0.1612 | +263.40% |
|
Dec 2022 (Q4)
|
$-38.75 | $-26.78 | -11.9750 | -44.72% |
Financial Statements
| Revenues | $18.05M |
| Benefits Costs and Expenses | $33.33M |
| Cost Of Revenue | $4.42M |
| Costs And Expenses | $20.81M |
| Gross Profit | $13.63M |
| Nonoperating Income/Loss | -$12.53M |
| Operating Expenses | $16.39M |
| Operating Income/Loss | -$2.76M |
| Income/Loss From Continuing Operations After Tax | -$15.29M |
| Income/Loss From Continuing Operations Before Tax | -$15.29M |
| Interest Expense, Operating | $2.44M |
| Net Income/Loss | -$15.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $241.00K |
| Preferred Stock Dividends And Other Adjustments | $241.00K |
| Basic Earnings Per Share | -$0.11 |
| Diluted Earnings Per Share | -$0.11 |
| Basic Average Shares | 262,310,013 |
| Diluted Average Shares | 6,560,398,653 |
| Assets | $7.52M |
| Current Assets | $6.08M |
| Inventory | $2.16M |
| Other Current Assets | $3.93M |
| Noncurrent Assets | $1.44M |
| Fixed Assets | $412.00K |
| Other Non-current Assets | $1.03M |
| Liabilities | $90.01M |
| Current Liabilities | $88.62M |
| Accounts Payable | $12.15M |
| Wages | $2.18M |
| Other Current Liabilities | $74.29M |
| Noncurrent Liabilities | $1.40M |
| Equity | -$87.52M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$87.52M |
| Temporary Equity | $5.03M |
| Temporary Equity Attributable To Parent | $5.03M |
| Liabilities And Equity | $7.52M |
| Net Cash Flow From Operating Activities | -$472.00K |
| Net Cash Flow From Operating Activities, Continuing | -$472.00K |
| Net Cash Flow From Investing Activities | -$5.00K |
| Net Cash Flow From Investing Activities, Continuing | -$5.00K |
| Net Cash Flow From Financing Activities | $14.00K |
| Net Cash Flow From Financing Activities, Continuing | $14.00K |
| Net Cash Flow | -$463.00K |
| Net Cash Flow, Continuing | -$463.00K |
| Comprehensive Income/Loss | -$18.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.11M |
| Other Comprehensive Income/Loss | -$18.11M |